NASDAQ · CHEA
Chenghe Acquisition Co.
$5.50-$0.08 (-1.44%)
Chenghe Acquisition Co.’s quoted price sits in the lower half of its reported 52-week range, 54.73% below the high.
Loading market information…
NASDAQ · IROH · USD
Stock price
Quote as of Sep 30, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Iron Horse Acquisitions Corp. Common Stock’s quoted price sits in the lower half of its reported 52-week range, 72.2% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Iron Horse Acquisitions Corp. currently lacks significant ongoing business activities. Its primary objective is to complete a strategic business combination, which could involve a merger, asset acquisition, stock exchange, or corporate reorganization, with one or more suitable enterprises. The firm's search for potential targets is concentrated on U.S.-based entities operating across various entertainment and media sectors, including content and film production, family entertainment, animation, music, gaming, e-sports, talent management, and talent-centric brands. This company was established in 2021 and maintains its headquarters in Toluca Lake, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:34 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$5.50-$0.08 (-1.44%)
Chenghe Acquisition Co.’s quoted price sits in the lower half of its reported 52-week range, 54.73% below the high.
$9.46-$1.50 (-13.69%)
Moringa Acquisition Corp’s quoted price sits in the lower half of its reported 52-week range, 30.22% below the high.
$5.85+$0.37 (+6.75%)
Phoenix Biotech Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 54.3% below the high.
$10.00+$1.58 (+18.76%)
Blue Safari Group Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 32.2% below the high.
$3.01-$6.15 (-67.14%)
A SPAC I Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 82.54% below the high.
$11.20+$0.09 (+0.81%)
Achari Ventures Holdings Corp. I’s quoted price sits in the upper half of its reported 52-week range, 10.04% below the high.
$11.20$0.00 (0.0%)
Greencity Acquisition Corporation’s quoted price sits in the lower half of its reported 52-week range, 12.23% below the high.
$0.29+$0.03 (+11.36%)
AEON Biopharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 79.72% below the high.
